SignatureFD’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4K | Hold |
71
| – | – | ﹤0.01% | 2382 |
|
|
2025
Q4 | $12.1K | Hold |
71
| – | – | ﹤0.01% | 2343 |
|
|
2025
Q3 | $9.36K | Sell |
71
-79
| -53% | -$9.48K | ﹤0.01% | 2429 |
|
|
2025
Q2 | $15.9K | Sell |
150
-1,388
| -90% | -$151K | ﹤0.01% | 2161 |
|
|
2025
Q1 | $191K | Buy |
1,538
+52
| +3% | +$6.78K | ﹤0.01% | 906 |
|
|
2024
Q4 | $183K | Sell |
1,486
-30
| -2% | -$3.54K | ﹤0.01% | 913 |
|
|
2024
Q3 | $169K | Buy |
1,516
+1,110
| +273% | +$122K | ﹤0.01% | 956 |
|
|
2024
Q2 | $43.3K | Sell |
406
-15
| -4% | -$1.65K | ﹤0.01% | 1575 |
|
|
2024
Q1 | $50.7K | Sell |
421
-112
| -21% | -$13.7K | ﹤0.01% | 1550 |
|
|
2023
Q4 | $65.6K | Sell |
533
-13
| -2% | -$1.62K | ﹤0.01% | 1341 |
|
|
2023
Q3 | $70.7K | Buy |
546
+252
| +86% | +$33.6K | ﹤0.01% | 1224 |
|
|
2023
Q2 | $36.4K | Sell |
294
-77
| -21% | -$10.4K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $54.3K | Buy |
371
+41
| +12% | +$6.07K | ﹤0.01% | 1345 |
|
|
2022
Q4 | $52.6K | Sell |
330
-31
| -9% | -$4.54K | ﹤0.01% | 1343 |
|
|
2022
Q3 | $48K | Sell |
361
-25
| -6% | -$3.8K | ﹤0.01% | 1288 |
|
|
2022
Q2 | $60K | Buy |
386
+22
| +6% | +$3.39K | ﹤0.01% | 1202 |
|
|
2022
Q1 | $57K | Buy |
364
+19
| +6% | +$2.76K | ﹤0.01% | 1308 |
|
|
2021
Q4 | $44K | Sell |
345
-70
| -17% | -$9.2K | ﹤0.01% | 1387 |
|
|
2021
Q3 | $54K | Sell |
415
-41
| -9% | -$6.2K | ﹤0.01% | 1264 |
|
|
2021
Q2 | $81K | Buy |
456
+46
| +11% | +$7.97K | ﹤0.01% | 1044 |
|
|
2021
Q1 | $67K | Buy |
410
+4
| +1% | +$658 | ﹤0.01% | 1038 |
|
|
2020
Q4 | $67K | Buy |
406
+32
| +9% | +$4.77K | ﹤0.01% | 949 |
|
|
2020
Q3 | $53K | Buy |
374
+34
| +10% | +$4.21K | ﹤0.01% | 952 |
|
|
2020
Q2 | $38K | Buy |
340
+80
| +31% | +$8.85K | ﹤0.01% | 1066 |
|
|
2020
Q1 | $26K | Buy |
260
+134
| +106% | +$17.3K | ﹤0.01% | 1133 |
|
|
2019
Q4 | $19K | Sell |
126
-40
| -24% | -$5.44K | ﹤0.01% | 1298 |
|
|
2019
Q3 | $21K | Sell |
166
-34
| -17% | -$4.56K | ﹤0.01% | 1198 |
|
|
2019
Q2 | $29K | Buy |
200
+72
| +56% | +$9.68K | ﹤0.01% | 1083 |
|
|
2019
Q1 | $18K | Buy |
128
+38
| +42% | +$4.96K | ﹤0.01% | 1220 |
|
|
2018
Q4 | $11K | Sell |
90
-160
| -64% | -$23.7K | ﹤0.01% | 1328 |
|
|
2018
Q3 | $42K | Sell |
250
-12
| -5% | -$2.06K | ﹤0.01% | 939 |
|
|
2018
Q2 | $45K | Buy |
262
+72
| +38% | +$11.8K | 0.01% | 894 |
|
|
2018
Q1 | $29K | Buy |
+190
| New | +$27.9K | ﹤0.01% | 928 |
|
|
2016
Q4 | – | Sell |
-52
| Closed | -$6K | – | 727 |
|
|
2016
Q3 | $6K | Hold |
52
| – | – | ﹤0.01% | 1178 |
|
|
2016
Q2 | $7K | Buy |
52
+13
| +33% | +$1.92K | ﹤0.01% | 1007 |
|
|
2016
Q1 | $5K | Buy |
39
+4
| +11% | +$498 | ﹤0.01% | 1007 |
|
|
2015
Q4 | $5K | Buy |
+35
| New | +$4.85K | ﹤0.01% | 903 |
|
Other funds holding JAZZ
VPM
VCM
EC
SignatureFD's JAZZ Position: Q1 2026 in Review
SignatureFD held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 71 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.
SignatureFD first reported a position in JAZZ in Q4 2015 and has held it in 37 quarters since. The position peaked at $191K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- SignatureFD held 71 shares of Jazz Pharmaceuticals worth $13.4K as of Q1 2026.
- SignatureFD left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2382 holding.
- SignatureFD first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 37 quarters since.
- SignatureFD's Jazz Pharmaceuticals position peaked at $191K in Q1 2025.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.